Clinical outcomes of conversion surgery following immune checkpoint inhibitors and chemotherapy in stage IV gastric cancer

CONCLUSIONS: Conversion surgery holds the potential for significant survival benefits in stage IV GC patients who have achieved a favorable clinical response to immunochemotherapy. Individuals with signet ring cell carcinoma may experience increased post-conversion surgery recurrence.PMID:37720943 | DOI:10.1097/JS9.0000000000000738

Source: Cancer Control - September 18, 2023 Category: Cancer & Oncology Authors: Huayuan Liang Xiao Yan Xinhua Chen Zhiwei Li Yaopeng Qiu Fengping Li Minghao Wang Zhicheng Huang Kaihua Huang Qing Xie Huimin Zhang Guoxin Li Hao Liu Liying Zhao Source Type: research